pectins and Streptococcal-Infections

pectins has been researched along with Streptococcal-Infections* in 2 studies

Other Studies

2 other study(ies) available for pectins and Streptococcal-Infections

ArticleYear
Effects of orange peels derived pectin on innate immune response, disease resistance and growth performance of Nile tilapia (Oreochromis niloticus) cultured under indoor biofloc system.
    Fish & shellfish immunology, 2018, Volume: 80

    The present study investigates the effects of orange peels derived pectin (OPDP) on skin mucus and serum immune parameters, disease resistance and growth performance of O. niloticus cultured under indoor biofloc system. Six hundred Nile tilapia (average weight 9.09 ± 0.05 g) were distributed into 15 fiber tanks (300 L per tank) assigned to five treatments repeated in triplicate. Fish were fed experimental diets contain different levels OPDP as follows: 0 (control in clear water), 0 (control in biofloc system), 5, 10, and 20 g kg

    Topics: Animals; Cichlids; Citrus sinensis; Complement Pathway, Alternative; Disease Resistance; Fish Diseases; Fruit; Immunity, Innate; Mucus; Muramidase; Pectins; Peroxidases; Phagocytosis; Respiratory Burst; Skin; Streptococcal Infections; Streptococcus agalactiae

2018
Application of DoE approach in the development of mini-capsules, based on biopolymers and manuka honey polar fraction, as powder formulation for the treatment of skin ulcers.
    International journal of pharmaceutics, 2017, Jan-10, Volume: 516, Issue:1-2

    The aim of the present work was the development of a powder formulation for the delivery of manuka honey (MH) bioactive components in the treatment of chronic skin ulcers. In particular pectin (PEC)/chitosan glutamate (CS)/hyaluronic acid (HA) mini-capsules were obtained by inverse ionotropic gelation in presence of calcium chloride and subsequently freeze-dried. Optimization of unloaded (blank) formulation was performed using DoE approach. In a screening phase, the following three factors were investigated at two levels: CS (0.5-1% w/w), PEC (0.5-1% w/w) and HA (0.3-0.5% w/w) concentrations. For the optimization phase a "central composite design" was used. The response variables considered were: particle size, buffer (PBS) absorption and mechanical resistance. In a previously work two different MH fractions were investigated, in particular MH fraction 1 (Fr1), rich in polar substances (sugars, methylglyoxal (MGO), dicarbonyl compounds, …), was able to enhance human fibroblasts in vitro proliferation. In the present work, the loading of MH Fr1 into mini-capsules of optimized composition determined a significant increase in cell proliferation in comparison with the unloaded ones. Loaded particles showed antimicrobial activity against Staphylococcus aureus and Streptococcus pyogenes; they were also able to improve wound healing in vivo on a rat wound model.

    Topics: Animals; Anti-Bacterial Agents; Biopolymers; Capsules; Chemistry, Pharmaceutical; Chitosan; Fibroblasts; Glutamic Acid; Honey; Humans; Hyaluronic Acid; Male; Pectins; Powders; Rats; Rats, Wistar; Skin Ulcer; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Wound Healing

2017